Drug Database
GL
glycopyrronium bromide (Sialanar)
✓ ApprovedProveca · Small Molecule · Small Molecule
What is glycopyrronium bromide?
glycopyrronium bromide is a small molecule developed by Proveca. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | Sialanar |
| Company | Proveca |
| Drug Class | Small Molecule |
| Route | Oral (PO) |
| Status | Approved |
Sources: ClinicalTrials.gov, Proveca
Therapeutic Indications
glycopyrronium bromide is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Gastrointestinal disorders | Salivary hypersecretion | ✓ Approved |
Related Research Articles
Unable to load articles right now.